Is Resonance Specialties Ltd (524218) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Resonance Specialties Ltd is a average quality company .

Is Resonance Specialties Ltd (524218) undervalued or overvalued?

The key valuation ratios of Resonance Specialties Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Resonance Specialties Ltd (524218) share price return in the past 10 years?

Resonance Specialties Ltd share price has appreciated 16.9% annually (CAGR) over the past ten years.

Is Resonance Specialties Ltd (524218) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Resonance Specialties Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Resonance Specialties Ltd (524218)?

Company share prices are keep on changing according to the market conditions. The current trading price of Resonance Specialties Ltd (524218) on 07-May-2026 14:59:00 at 14:59 is 107.14.

What is the market cap of Resonance Specialties Ltd (524218)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 07-May-2026 at 14:59, the market cap of Resonance Specialties stood at Rs. 118.21 Cr.

What is the P/E ratio of Resonance Specialties?

The latest standalone P/E ratio of Resonance Specialties as of 07-May-2026 is 13.35.

What is the P/B ratio of Resonance Specialties Ltd (524218)?

The latest standalone P/B ratio of Resonance Specialties Ltd (524218) as of 07-May-2026 is 1.82.

What is the 52-week high and low of Resonance Specialties Ltd (524218)?

The 52-week high of Resonance Specialties Ltd (524218) is Rs. 124.50 and the 52-week low is Rs. 69.01.

What is the TTM revenue of Resonance Specialties Ltd (524218)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Resonance Specialties is Rs. 89.97 (Cr.).

Resonance Specialties Ltd (524218) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Resonance Specialties Ltd (524218)
Brand: Resonance Specialties

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	11.4%	8.6%	3.1%	25.3%	31.5%	48.3%	39.8%	14.1%	7.8%	15.2%	-
Value Creation Index ⓘ	-0.2	-0.4	-0.8	0.8	1.3	2.5	1.8	0.0	-0.4	0.1	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	38.9	34.2	36	40.3	56.1	70.3	75.8	58.8	55.3	77.8	90
Sales YoY Gr.	-	-12.2%	5.2%	12%	39.4%	25.2%	7.8%	-22.4%	-6%	40.7%	-
Adj EPS ⓘ	1.1	0.8	-0.7	2.6	5.4	8.7	10.4	3.9	2.3	6.1	7.7
YoY Gr.	-	-27.6%	-197.4%	NA	106.9%	61.9%	19.9%	-62.6%	-40.3%	159.7%	-
BVPS (₹) ⓘ	14.8	15.9	15.3	18.1	21.6	30.4	40	43.4	46.6	52.3	56.3
Adj Net Profit ⓘ	1.2	0.9	-0.9	3	6.2	10.1	12.1	4.5	2.7	7	9
Cash Flow from Ops. ⓘ	3.2	0.6	2.1	5.3	1.4	4.3	13.3	-8.4	4.2	-2.5	-
Debt/CF from Ops. ⓘ	0.6	7.3	1.6	0	0.3	0.3	0	-0.3	1	-1.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	8%	6.8%	0.9%	40.7%
Adj EPS ⓘ	21.5%	2.4%	-16.6%	159.7%
BVPSⓘ	15.1%	19.4%	9.3%	12.1%
Share Price	16.9%	-4.9%	8.1%	39.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	5.5	3.8	-3.6	12.1	21.8	28.2	26.1	8.4	4.8	11.5	14.1
Op. Profit Mgn % ⓘ	8.1	5.9	1.8	12	13.8	20.3	22.1	11.6	8.7	13.9	14
Net Profit Mgn % ⓘ	3.1	2.6	-2.4	7.5	11.1	14.3	15.9	7.7	4.9	9	9.8
Debt to Equity ⓘ	0.1	0.2	0.2	0	0	0	0	0	0.1	0.1	-
Working Cap Days ⓘ	163	204	212	171	126	128	141	208	286	231	108
Cash Conv. Cycle ⓘ	83	104	86	63	57	59	69	134	184	164	88

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 14.10%

Sales growth is good in last 4 quarters at 28.99%

Sales growth has been subdued in last 3 years 0.89%

Net Profit has been subdued in last 3 years -16.63%

	Standalone	Consolidated
TTM EPS (₹)	7.7	-
TTM Sales (₹ Cr.)	90	-
BVPS (₹) ⓘ	56.3	-
Reserves (₹ Cr.) ⓘ	53	-
P/BV ⓘ	1.82	-
PE ⓘ	13.35	-

From the Market
52 Week Low / High (₹)	69.01 / 124.50
All Time Low / High (₹)	1.05 / 254.95
Market Cap (₹ Cr.)	118
Equity (₹ Cr.)	11.5
Face Value (₹)	10
Industry PE ⓘ	47.8

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	39	34	36	40	56	70	76	59	55	78
Operating Expenses ⓘ +	36	32	35	35	48	56	59	52	50	67
Manufacturing Costs	12	13	13	12	21	23	28	31	18	29
Material Costs	18	13	16	18	21	26	24	13	24	30
Employee Cost	2	3	4	3	4	4	4	4	5	5
Other Costs ⓘ	3	3	2	2	2	3	2	4	3	3
Operating Profit ⓘ	3	2	1	5	8	14	17	7	5	11
Operating Profit Margin (%)	7.8%	5.9%	1.8%	12.0%	13.8%	20.3%	22.1%	11.6%	8.7%	13.6%
Other Income ⓘ +	0	1	1	1	2	2	1	2	1	1
Exceptional Items ⓘ	0	0	-0	-0	-1	0	0	0	0	-1
Interest ⓘ	1	0	1	1	0	0	0	0	0	0
Depreciation ⓘ	1	1	1	1	1	1	2	1	1	2
Profit Before Tax ⓘ	2	1	0	5	7	15	16	7	4	9
Tax ⓘ	0	0	1	2	1	4	4	2	1	2
Profit After Tax	1	1	-1	3	6	11	12	5	3	7
PAT Margin (%)	3.1%	3.0%	-1.9%	8.0%	9.8%	15.0%	16.3%	8.5%	5.4%	8.4%
Adjusted EPS (₹)	1.0	0.9	-0.6	2.8	4.8	9.1	10.7	4.3	2.6	5.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	21%	11%	9.30%	23.10%	0%	17.60%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	23	24	23	26	31	41	52	56	57	64
Share Capital ⓘ	12	12	12	12	12	12	12	12	12	12
Reserves ⓘ	11	12	12	15	19	29	40	44	46	52
Debt +	2	4	3	0	0	1	0	2	3	2
Long Term Debt	0	0	0	0	0	0	0	2	3	2
Short Term Debt	2	4	3	0	0	1	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	5	9	6	7	7	8	1	5	9	5
Others Liabilities ⓘ	2	3	4	5	4	5	4	3	4	4
Total Liabilities ⓘ	32	40	37	38	41	55	57	66	74	76
Fixed Assets
Net Fixed Assets ⓘ +	14	15	15	14	14	16	14	20	23	21
Gross Block	39	41	41	42	42	45	44	52	56	50
Accumulated Depreciation	25	26	27	27	28	29	30	32	33	28
CWIP ⓘ	0	0	1	1	2	0	0	0	0	1
Investments ⓘ	0	0	0	0	0	1	0	0	3	0
Inventories	8	14	10	9	13	17	12	23	23	26
Trade Receivables	7	7	7	8	6	9	8	12	13	22
Cash Equivalents	1	1	1	2	2	6	9	4	2	1
Others Assets ⓘ	3	3	4	5	3	6	14	6	9	4
Total Assets ⓘ	32	40	37	38	41	55	57	66	74	76

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	3	1	2	5	1	4	13	-8	4	-3
PBT ⓘ	1	1	0	5	7	15	16	7	4	9
Adjustment ⓘ	2	2	2	1	-1	1	1	1	1	2
Changes in Working Capital ⓘ	1	-2	1	-1	-3	-7	1	-14	0	-12
Tax Paid ⓘ	-0	-0	-0	0	-2	-4	-5	-2	-1	-2
Cash Flow From Investing Activity ⓘ +	-1	-3	-1	-1	-2	-1	-9	3	-7	2
Capex	-1	-3	-1	-1	-2	-1	-0	-8	-4	-1
Net Investments	0	0	0	0	-0	-1	1	0	-3	3
Others ⓘ	0	0	0	0	0	0	-9	11	0	0
Cash Flow From Financing Activity ⓘ +	-2	2	-1	-4	1	0	-2	1	0	-1
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-0	0	-0	-0	0	0	0	2	1	-1
Interest Paid ⓘ	-1	-0	-0	-0	-0	-0	-0	-0	-0	-0
Dividend Paid ⓘ	-1	0	0	0	1	0	-1	-1	-1	0
Others ⓘ	-1	2	-1	-3	0	1	-1	0	1	0
Net Cash Flow ⓘ	0	-0	0	1	1	3	3	-4	-2	-2

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	7.24	5.8	-3.86	16.66	24.08	35.11	30.44	10.39	5.71	11.5
ROCE (%)	11.37	8.62	3.14	25.29	31.51	48.33	39.75	14.14	7.79	15.2
Asset Turnover Ratio	1.24	1.03	1.01	1.21	1.61	1.63	1.53	1.07	0.79	1.04
PAT to CFO Conversion(x)	3	1	N/A	1.67	0.17	0.36	1.08	-1.6	1.33	-0.43
Working Capital Days
Receivable Days	76.10	71	66.10	57.10	39.20	36.50	37.80	56.90	84.70	83.70
Inventory Days	68.50	106.30	110.40	75.50	63.70	70.20	60.60	96.40	151.60	115.10
Payable Days	119	199.90	165.20	130.10	116.60	107.30	72.50	84.80	103.80	86.80

About Resonance Specialties Ltd

Resonance Specialties incorporated in 1989 is a pioneer in Pyridine chemistry and one of the few manufacturers of the product in the world. The company, formerly known as Armour Polymers Limited, was the first in India to manufacture Pyridines. Resonance is also one of the largest manufacturers of Lutidines in the world.Despite the fact that these technologies are available only with a select few companies worldwide, Resonance was able to innovate and commercialise production with its own technology.

The company is promoted by Dr Atma. B. Gupta, a technocrat with a doctorate from the University of New York, and several years of post doctorate research in USA.

The company produces a range of value added products and continues to be the largest manufacturer and exporter of products like Alpha Picolinic acid and Dipicolinic acid. Resonance has exclusive supply arrangements with global industry leaders.

In 1994, just two years after the commissioning of the Pyridine and Picoline plants, the company repeated its pioneering feat. It became the first company in India to manufacture Cyanopyridines. This successful effort brought company recognition from the government of India for technological excellence. Resonance is also the first in India to manufacture various Collidines. True to its ethos, products manufactured by the company are comparable to the worldâ€™s best. The company employs green manufacturing to minimise its ecological impact and is able to deliver products that meet and surpass customer expectations and standards. Many of their innovative processes improve the yield; enhance the efficiency of manufacturing as well as the quality of the product.

Resonance products are exported to many countries worldwide through their supply agreements with many multinationals as well as through direct exports.In the company, quality is a way of life and it adhere to a stringent regimen to ensure the quality of their products.Every raw material is thoroughly tested and quality is monitored through the entire manufacturing process up to the final packaging.

Product range of the company includes:

Pyridines
Picolines
Cyanopyridines
Lutidines
Collidines
Active Pharmaceutical Ingredients (APIs)
Drug Intermediates

These products cater to the requirements of various industries.

Pyridine is a versatile chemical used in the manufacture of agrochemicals,pharmaceuticals & bulk drugs, dyes, rubber chemicals, etc
Alpha Picoline is used in the Vinyl Latex Rubber.
Beta Picoline is used in the manufacture of Vitamin B3.
Gamma Picoline is used in the pharmaceutical industry for the manufacture of an anti-tuberculosis drug, Isoniazid

Resonance products are exported to many countries worldwide through its supply agreements with many multinationals as well as through direct exports.

Achievements/ recognition

The promoter of the company is the proud recipient of the Government of India award for technological excellence when he set up the first Cyanopyridines plant in India.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Resonance Specialties Ltd (524218) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Resonance Specialtie Share Price